We are live on ! Find out more
BRM

Boston Research & Management Portfolio holdings

AUM $421M
1-Year Est. Return 16.18%
This Fund
S&P 500
This Quarter Est. Return
-17.42%
1 Year Est. Return
+16.18%
3 Year Est. Return
+48.21%
5 Year Est. Return
+65.09%
10 Year Est. Return
+242.1%
AUM
$199M
AUM Growth
-$67.4M
Cap. Flow
-$19.4M
Cap. Flow %
-9.76%
Top 10 Hldgs %
29.62%
Holding
101
New
Increased
15
Reduced
52
Closed
9

Top Sells

Rank Stock Value
1
RTX icon
RTX Corp
RTX
+$4.22M
2
AAPL icon
Apple
AAPL
+$2.19M
3
MOS icon
The Mosaic Company
MOS
+$1.73M
4
INTC icon
Intel
INTC
+$1.58M
5
COP icon
ConocoPhillips
COP
+$1.11M

Sector Composition

Rank Sector Weight
1 Technology 15.82%
2 Healthcare 14.1%
3 Consumer Staples 13.8%
4 Industrials 10.73%
5 Communication Services 9.11%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CMCSA icon
26
Comcast
CMCSA
$88.5B
$3.54M 1.78%
103,129
-2,221
-2% -$93.7K
IEMG icon
27
iShares Core MSCI Emerging Markets ETF
IEMG
$156B
$3.33M 1.67%
82,246
-11,314
-12% -$556K
UPS icon
28
United Parcel Service
UPS
$92.7B
$3.27M 1.64%
35,006
-1,114
-3% -$115K
KO icon
29
Coca-Cola
KO
$372B
$3.1M 1.56%
70,188
-16,613
-19% -$897K
CHRW icon
30
C.H. Robinson
CHRW
$18.1B
$3.07M 1.54%
46,331
-1,697
-4% -$122K
DIS icon
31
Walt Disney
DIS
$170B
$2.99M 1.5%
30,947
-273
-0.9% -$34.5K
LIN icon
32
Linde
LIN
$223B
$2.98M 1.5%
17,240
-400
-2% -$78.9K
LH icon
33
Labcorp
LH
$25.3B
$2.93M 1.47%
26,999
-863
-3% -$124K
MMM icon
34
3M
MMM
$93.6B
$2.82M 1.41%
24,673
-2,079
-8% -$273K
IEFA icon
35
iShares Core MSCI EAFE ETF
IEFA
$194B
$2.47M 1.24%
49,533
-11,809
-19% -$703K
IWM icon
36
iShares Russell 2000 ETF
IWM
$83B
$2.46M 1.24%
21,542
-548
-2% -$81.7K
BNY
37
Bank of New York Mellon
BNY
$106B
$2.43M 1.22%
72,088
-5,249
-7% -$220K
WU icon
38
Western Union
WU
$2.28B
$2.27M 1.14%
125,241
-38,579
-24% -$946K
OMC icon
39
Omnicom Group
OMC
$22.4B
$2.16M 1.09%
39,406
-8,041
-17% -$571K
HYG icon
40
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
$16.6B
$1.89M 0.95%
24,501
+340
+1% +$28.7K
USB icon
41
US Bancorp
USB
$100B
$1.85M 0.93%
53,737
-13,108
-20% -$632K
BBH icon
42
VanEck Biotech ETF
BBH
$405M
$1.85M 0.93%
14,443
+298
+2% +$40.1K
SPY icon
43
State Street SPDR S&P 500 ETF Trust
SPY
$821B
$1.84M 0.93%
7,152
IAU icon
44
iShares Gold Trust
IAU
$63.3B
$1.78M 0.89%
59,060
-800
-1% -$24.2K
HD icon
45
Home Depot
HD
$347B
$1.77M 0.89%
9,495
-100
-1% -$22K
XOM icon
46
ExxonMobil
XOM
$638B
$1.62M 0.81%
42,598
-18,495
-30% -$1.02M
VTI icon
47
Vanguard Morningstar Total Stock Market ETF
VTI
$683B
$1.59M 0.8%
12,380
VB icon
48
Vanguard Morningstar Small-Cap ETF
VB
$82.3B
$1.43M 0.72%
12,367
-3,154
-20% -$474K
IBB icon
49
iShares Biotechnology ETF
IBB
$9.39B
$1.4M 0.7%
13,009
-425
-3% -$48.9K
COP icon
50
ConocoPhillips
COP
$144B
$1.25M 0.63%
40,620
-21,801
-35% -$1.11M

Similar funds

Boston Research & Management's Q1 2020 Portfolio in Review

As of Q1 2020, Boston Research & Management held 101 positions worth $199M, down 25% from $267M the previous quarter. Its ten largest holdings account for 30% of the portfolio.

Boston Research & Management withdrew a net $19.4M in Q1 2020, closing 9 positions and reducing 52 holdings. Its most notable exit was The Mosaic Company, an estimated $1.73M position sold in full.

By sector, the portfolio is most concentrated in Technology at 16% of assets, up from 15% a quarter earlier, followed by Healthcare and Consumer Staples.

Against the trend, Boston Research & Management added an estimated $2.58M to iShares Core S&P 500 ETF.

  • Boston Research & Management added most to iShares Core S&P 500 ETF in Q1 2020, an estimated $2.58M increase.
  • Boston Research & Management's biggest Q1 2020 reduction was RTX Corp, cutting an estimated $4.22M.
  • Boston Research & Management fully exited The Mosaic Company in Q1 2020, selling an estimated $1.73M.
  • Boston Research & Management's ten largest holdings make up 30% of its $199M portfolio in Q1 2020.
  • Boston Research & Management opened 0 new positions and closed 9 in Q1 2020.
  • Boston Research & Management's portfolio value fell 25% quarter-over-quarter to $199M.

Based on Boston Research & Management's 13F filing for Q1 2020, filed 8 May 2020.